Month: Juli 2020

Dr. Duerrschmid will speak about his academic work in cardiovascular immunology and his current role at Akoya Biosciences. Akoya Biosciences offers multiplex immunofluorescence solutions to detect up to 40 biomarkers on intact tissue sections. This approach allows researchers to interrogate cells within their spatial context, in turn enabling improved patient stratification in preclinical trials, in immuno-oncology, neuroscience, transplant biology, infectious diseases, and beyond.

Dr. Stadlbauer will describe his role in developing a serological enzyme-linked immunosorbent assay (ELISA) for the screening and identification of human SARS-CoV-2 seroconverters. This assay does not require the handling of infectious virus, can be adjusted to detect different antibody types in serum and plasma and is amenable to scaling. Serological assays are of critical importance to help define previous exposure to SARS-CoV-2 in populations, identify highly reactive human donors for convalescent plasma therapy and investigate correlates of protection.